First Hawaiian Bank’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,530
Closed -$233K 878
2023
Q2
$233K Hold
2,530
0.01% 776
2023
Q1
$262K Hold
2,530
0.01% 750
2022
Q4
$292K Hold
2,530
0.01% 708
2022
Q3
$274K Sell
2,530
-753
-23% -$108K 0.01% 696
2022
Q2
$593K Buy
3,283
+753
+30% +$135K 0.02% 482
2022
Q1
$432K Hold
2,530
0.01% 660
2021
Q4
$530K Buy
2,530
+467
+23% +$96.5K 0.02% 619
2021
Q3
$397K Sell
2,063
-7
-0.3% -$1.72K 0.02% 608
2021
Q2
$586K Buy
2,070
+3
+0.1% +$813 0.02% 456
2021
Q1
$438K Buy
+2,067
New +$495K 0.02% 580
2019
Q4
Sell
-5,238
Closed -$543K 859
2019
Q3
$543K Buy
5,238
+1,304
+33% +$140K 0.03% 421
2019
Q2
$505K Buy
+3,934
New +$547K 0.03% 452
2019
Q1
Sell
-35
Closed -$4K 1779
2018
Q4
$4K Sell
35
-5
-13% -$855 ﹤0.01% 1639
2018
Q3
$9K Buy
+40
New +$8.11K ﹤0.01% 1556

Other funds holding MED

First Hawaiian Bank's MED Position: Q3 2023 in Review

First Hawaiian Bank sold out of Medifast (MED) in Q3 2023, closing a stake of 2,530 shares — an estimated $233K sold.

First Hawaiian Bank first reported a position in MED in Q3 2018 and held it in 14 quarters. The position peaked at $593K in Q2 2022. 223 funds tracked by Wall St. Rank hold MED as of Q3 2023.

  • First Hawaiian Bank reported no remaining Medifast position as of Q3 2023 after selling out during the quarter.
  • First Hawaiian Bank sold 2,530 Medifast shares in Q3 2023, an estimated $233K.
  • First Hawaiian Bank first reported a position in Medifast in Q3 2018 and held it in 14 quarters.
  • First Hawaiian Bank's Medifast position peaked at $593K in Q2 2022.
  • 223 funds tracked by Wall St. Rank held Medifast as of Q3 2023.

Based on First Hawaiian Bank's 13F filing for Q3 2023, filed 10 Oct 2023.